María Lorena Brance , Agustín Razzini , Bernardo A. Pons-Estel , Norberto J. Quagliato , Marisa Jorfen , Guillermo Berbotto , Lucas R. Brun
{"title":"Whole-hand and regional bone mineral density involvement in rheumatoid arthritis","authors":"María Lorena Brance , Agustín Razzini , Bernardo A. Pons-Estel , Norberto J. Quagliato , Marisa Jorfen , Guillermo Berbotto , Lucas R. Brun","doi":"10.1016/j.reumae.2023.04.005","DOIUrl":"https://doi.org/10.1016/j.reumae.2023.04.005","url":null,"abstract":"<div><p><span>Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by symmetric polyarthritis that can lead to joint deformity, disability, and osteoporosis. We aimed to evaluate whole hand and regional BMD in RA patients compared to controls. In addition, we evaluated the BMD of dominant versus non-dominant hands in healthy subjects. We included adult female and male RA patients and control subjects matched by age, sex, and BMI. BMD (g/cm</span><sup>2</sup><span>) was measured by DXA in lumbar spine (LS), whole hand, and three regions of interest: carpus, metacarpal bones, and phalanges. Results: 44 control subjects (49.5</span> <!-->±<!--> <!-->11.8 y) and 60 with RA (52.7<!--> <!-->±<!--> <!-->12.7 y) were included. Significant lower BMD in RA patients was found in LS (−8.7%), dominant whole hand (−9.5%), carpus, metacarpal bones, and phalanges, and non-dominant whole hand (−8.7%), metacarpal bones, and phalanges compared to controls. A significant positive correlation was found between LS and whole-hand BMD (dominant <em>r</em> <!-->=<!--> <!-->.63, non-dominant <em>r</em> <!-->=<!--> <!-->.67). Finally, the whole hand, metacarpal bones, and carpus BMD measurements were significantly higher in the dominant hand compared to the non-dominant hand without differences in the phalangeal ROI. In conclusion, hand BMD was significantly lower in RA patients compared to control subjects and there was a significant correlation with LS BMD. We demonstrated that BMD measurements of the whole-hand, and different ROI (carpus, metacarpal bones, and phalanges) by DXA would be an easily reproducible technique to evaluate bone loss. In addition, the whole hand, metacarpal bones and carpus BMD measurements were significantly higher in the dominant hand compared to the non-dominant hand without differences in the phalanges.</p></div>","PeriodicalId":94193,"journal":{"name":"Reumatologia clinica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138484273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pía Lois , Leticia López Pedraza , María Rodero , Teresa Mulero , Cristina Lajas , Esther Toledano , Leticia Leon , Luis Rodríguez , Benjamin Fernandez Gutierrez , Lydia Abasolo , Gloria Candelas
{"title":"Emerging trends in nurse-led programs of care for management of patients with established rheumatoid arthritis: Systematic literature review","authors":"Pía Lois , Leticia López Pedraza , María Rodero , Teresa Mulero , Cristina Lajas , Esther Toledano , Leticia Leon , Luis Rodríguez , Benjamin Fernandez Gutierrez , Lydia Abasolo , Gloria Candelas","doi":"10.1016/j.reumae.2023.10.004","DOIUrl":"https://doi.org/10.1016/j.reumae.2023.10.004","url":null,"abstract":"<div><h3>Introduction</h3><p>In patients with rheumatoid arthritis (RA), nurses are considered as essential, not only to ensure pharmacological safety, but also in the promotion in self-care and decision-making, favouring the empowerment of patients. This systematic review aimed to summarize the available literature on the health education by the nurse in patients with RA.</p></div><div><h3>Material and methods</h3><p>Following Cochrane Collaboration procedures, the PRISMA statement and PRISMA checklist, relevant quantitative studies published were retrieved from the CINAHL, Scopus, PubMed and Medic databases and then systematically reviewed. The search ended in August 2021. Nineteen studies were retained for inclusion and evaluated with the Scottish Intercollegiate Guidelines Network for Systematic Reviews.</p></div><div><h3>Results</h3><p>We found statistically significant improvement in self-care (five studies), disease activity (three studies), quality of life (two studies), satisfaction (five studies) and adherence (one study) with the nursing-led management of patients with established rheumatoid arthritis.</p></div><div><h3>Discussion</h3><p>Although there is solid evidence of improvement in satisfaction and self-care, there seems to be a trend also to improve other outcomes, such as DAS28, from the EULAR recommendations, the expansion of the therapeutic arsenal for rheumatoid arthritis and shared decision-making. In addition, recently and due to the implementation of new technologies, the role of the nurse has been evaluated through virtual consultations. The results of recent studies have shown that this an effective and well-accepted novel approach for the management of patients with stable rheumatoid arthritis.</p></div><div><h3>Conclusion</h3><p>Our study suggests that nurse-led health education, in addition of improvement in satisfaction and self-care, improve activity disease scores in RA patients.</p></div>","PeriodicalId":94193,"journal":{"name":"Reumatologia clinica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138484213","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Carlota Iñiguez Ubiaga , Carlos García Porrúa , José Antonio Pinto Tasende , Lorena Paula Iñiguez Ubiaga , Amalia Sánchez-Andrade Fernandez
{"title":"Liver fibrosis 4 score: Use in the evaluation of non-alcoholic fatty liver disease in patients with psoriatic arthritis","authors":"Carlota Iñiguez Ubiaga , Carlos García Porrúa , José Antonio Pinto Tasende , Lorena Paula Iñiguez Ubiaga , Amalia Sánchez-Andrade Fernandez","doi":"10.1016/j.reumae.2023.04.004","DOIUrl":"https://doi.org/10.1016/j.reumae.2023.04.004","url":null,"abstract":"<div><h3>Objectives</h3><p>To describe the prevalence of non-alcoholic fatty liver disease (NAFLD), the association between FIB4 and ultrasound findings, and the clinical characteristics of psoriatic arthritis patients.</p></div><div><h3>Material and methods</h3><p>We carried out an observational cross-sectional study of patients seen in the outpatient clinic from January 1st, 2020, to November 30th, 2020, with psoriatic arthritis.</p></div><div><h3>Results</h3><p>Of the 90 patients studied, the prevalence of NAFLD was 56.67%. FIB4 presents an association with ultrasound findings (p = .030), the absence of enthesitis (p = .036), and longer duration of disease (Rho .213 p = .042). It also presents an association with hypertension (p = .027) and alcohol consumption (p = .021). However, biological treatment can be considered as a protective factor (p = .005). FIB4 acts as a NAFLD predictor with 69.2% sensitivity and 70.4% specificity.</p></div><div><h3>Conclusions</h3><p>The prevalence of NAFLD was higher in our sample than in the standard population. FIB4 index may be useful in screening for silent liver damage in psoriatic arthritis in clinical practice.</p></div>","PeriodicalId":94193,"journal":{"name":"Reumatologia clinica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71732675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Non-surgical treatment of aseptic olecranon bursitis: A systematic review","authors":"Ikwinder Preet Kaur , Mohsin Sheraz Mughal , Fawad Aslam , Jennifer Schram , Pankaj Bansal","doi":"10.1016/j.reumae.2023.05.004","DOIUrl":"https://doi.org/10.1016/j.reumae.2023.05.004","url":null,"abstract":"<div><h3>Objective</h3><p>Olecranon bursitis (OB), characterized by inflammation and fluid collection in the olecranon bursa is a commonly encountered out-patient condition. The data is heterogeneous regarding a stepwise and standardized approach to aseptic OB treatment and the efficacy of intra-bursal corticosteroid injections (CSI). The objective of this review is to systematically evaluate the non-surgical treatment options for aseptic OB.</p></div><div><h3>Methods</h3><p>This systematic review was conducted in accordance with PRISMA recommendations. The English and non-English literature search was performed in 5 medical databases to identify studies evaluating the treatment of OB. All included studies were evaluated for risk of bias (RoB) using the revised Cochrane RoB tool for randomized control trials (RCTs) and the Newcastle-Ottawa Scale (NOS) for case–control and cohort studies.</p></div><div><h3>Results</h3><p>For the final analyses, 2 RCTs and 2 observational studies were included. The RoB for the RCTs was high and both failed to demonstrate a significant difference in terms of the resolution of OB and bursal tenderness among various invasive and non-invasive treatment options. Corticosteroid injection (CSI) was associated with a significant decline in the duration of symptoms. However, it was associated with a higher number of complications including bursal infection and skin atrophy.</p></div><div><h3>Conclusion</h3><p>Based on the available data, it appears that the clinical resolution of aseptic OB can occur with conservative methods if implemented earlier in the disease course. Although CSI is more effective than other treatments, it should be reserved for refractory cases because of a higher complication rate.</p></div>","PeriodicalId":94193,"journal":{"name":"Reumatologia clinica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71732677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pablo González del Pozo, Stefanie Burger, Estefanía Pardo Campo, Mercedes Alperi López, Rubén Queiro Silva, Sara Alonso Castro
{"title":"Acroosteolysis and facial dysmorphia: a new case of Hajdu-Cheney syndrome","authors":"Pablo González del Pozo, Stefanie Burger, Estefanía Pardo Campo, Mercedes Alperi López, Rubén Queiro Silva, Sara Alonso Castro","doi":"10.1016/j.reumae.2023.10.001","DOIUrl":"10.1016/j.reumae.2023.10.001","url":null,"abstract":"<div><p><span><span>Hajdu-Cheney syndrome or acro-dento-osteo-dysplasia syndrome is a rare disease characterized by band osteolysis of </span>distal phalanges<span> and facial dysmorphia, among other manifestations. We present the case of a 45-year-old male who consulted for mechanical </span></span>joint pain<span> of both hands, facial dysmorphism, cranio-facial alterations, and digital telescoping with acroosteolysis.</span></p></div>","PeriodicalId":94193,"journal":{"name":"Reumatologia clinica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49686902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Increased circulating interleukin-23 level in patients with sarcoidosis","authors":"Senol Kobak , Huseyin Semiz , Muhittin Akyildiz , Ayse Gokduman , Tennur Atabay , Huseyin Vural","doi":"10.1016/j.reumae.2022.11.007","DOIUrl":"https://doi.org/10.1016/j.reumae.2022.11.007","url":null,"abstract":"<div><h3>Background</h3><p>Sarcoidosis is a Th1-mediated chronic inflammatory disease characterized by non-caseating granulomas. Its pathogenesis is not yet clear, but the possible role of various proinflammatory cytokines is being discussed.</p></div><div><h3>Aim</h3><p>This study aims to determine serum cytokine (IL-6, IL-12, IL-17, and IL-23) levels in patients with sarcoidosis, and to determine a possible correlation with clinical and laboratory findings of the disease.</p></div><div><h3>Material and method</h3><p>Forty-four biopsy-proven sarcoidosis patients followed up at a single centre and 41 healthy volunteers were included in the study. Demographic, clinical, laboratory, and radiological data of all patients were recorded. Serum samples from the patients and the control group were taken and IL-6, IL-12, IL-17, IL-23 were measured by ELISA method.</p></div><div><h3>Results</h3><p>Of the 44 sarcoidosis patients, 13(29.5%) were male and 31(70.5%) were female. Average patient age was 47.4 years, mean disease duration was 3.2 years. Twenty-one (47.7%) patients had erythema nodosum, three (6.8%) had uveitis, 40(90.9%) had arthralgia, 23(52.3%) had ankle arthritis, 15(34.1%) had enthesitis. Laboratory evaluation showed increased serum ACE levels in 24(54.5%) patients, increased serum calcium levels in 11 (25%) patients, increased serum D3 levels in 5(11.4%) patients, increased ESR and CRP levels in 22(50%) and 23(52.3%) patients, respectively. Compared with the control group higher serum IL-23 levels were found in the patients with sarcoidosis (<em>p</em> <!-->=<!--> <!-->.01). Serum IL-23 was associated with ankle arthritis (<em>p</em> <!-->=<!--> <!-->.02). Serum IL-6, IL-12, and IL-17 levels were similar in the sarcoidosis patients and the control group (<em>p</em> <!-->=<!--> <!-->.128, <em>p</em> <!-->=<!--> <!-->.212, <em>p</em> <!-->=<!--> <!-->.521 respectively).</p></div><div><h3>Conclusion</h3><p>In our study, we found increased serum IL-23 in patients with sarcoidosis, while serum IL-6, IL-12, and IL-17 were detected as normal. Although our results are somewhat contradictory to other studies in the literature, the question should still be whether sarcoidosis is a Th1/Th17 disease. Multicentre studies are needed in this regard.</p></div>","PeriodicalId":94193,"journal":{"name":"Reumatologia clinica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71732676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Carmen Lobo Rodríguez , Ana M. López-Calleja , Paloma Morales de los Ríos Luna , Susana Sánchez Vázquez , Ángela Molinero Sampedro , Amparo López-Esteban
{"title":"Comparison of the first and sixth waves of the SARS-COV-2 coronavirus pandemic in patients with immune-mediated disease","authors":"Carmen Lobo Rodríguez , Ana M. López-Calleja , Paloma Morales de los Ríos Luna , Susana Sánchez Vázquez , Ángela Molinero Sampedro , Amparo López-Esteban","doi":"10.1016/j.reumae.2023.02.011","DOIUrl":"10.1016/j.reumae.2023.02.011","url":null,"abstract":"<div><h3>Introduction</h3><p><span>Recent evidence shows that COVID-19 infection does not have a worse prognosis in patients with immune-mediated </span>inflammatory diseases (IMID), although they develop a worse response to vaccination.</p></div><div><h3>Objective</h3><p>To compare the incidence of COVID-19 and clinical features in patients with IMID between the first and sixth waves.</p></div><div><h3>Method</h3><p>Prospective observational study of two cohorts of IMID patients diagnosed with COVID-19. First cohort March to May 2020, and second cohort December/2021 to February/2022.</p><p>Sociodemographic and clinical variables were collected and, in the second cohort, COVID-19 vaccination status. Statistical analysis established differences in characteristics and clinical course between the two cohorts.</p></div><div><h3>Results</h3><p><span>In total, 1627 patients were followed up, of whom 77 (4.60%) contracted COVID-19 during the first wave and 184 in the sixth wave (11.3%). In the sixth wave, there were fewer hospitalisations, intensive care unit admissions, and deaths than in the first wave (</span><em>p</em> <!-->=<!--> <!-->.000) and 180 patients (97.8%) had at least one dose of vaccine.</p></div><div><h3>Conclusion</h3><p>Early detection and vaccination have prevented the occurrence of serious complications.</p></div>","PeriodicalId":94193,"journal":{"name":"Reumatologia clinica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9954514","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Natalia de la Torre Rubio, Marina Pavía Pascual, José Campos Esteban, Hilegarda Godoy Tundidor, Mónica Fernández Castro, José Luis Andréu Sánchez
{"title":"Usefulness of an electronic consultation system between primary care health centres and the rheumatology department of a tertiary hospital","authors":"Natalia de la Torre Rubio, Marina Pavía Pascual, José Campos Esteban, Hilegarda Godoy Tundidor, Mónica Fernández Castro, José Luis Andréu Sánchez","doi":"10.1016/j.reumae.2022.12.008","DOIUrl":"10.1016/j.reumae.2022.12.008","url":null,"abstract":"<div><h3>Background and objective</h3><p>Rheumatic diseases<span><span> account for almost 30% of consultations attended in Spanish primary care centres. The main objective was to analyse the demand for </span>rheumatology consultations from Primary Care and their resolution using the electronic consultation system.</span></p></div><div><h3>Patients and methods</h3><p>Retrospective descriptive study of electronic consultations from primary care centres in the health area to the Rheumatology service of a tertiary hospital, between July 2020 and May 2021.</p></div><div><h3>Results</h3><p><span>The last 500 consecutive consultations were collected. Mean age of patients was 59.5 years; 74.2% were women. Main reasons for consultation were osteoporosis<span> and treatment<span> of patients with rheumatoid arthritis and </span></span></span>spondyloarthritis under follow-up by the department. Mean response time was 2 days. Fifty-seven per cent of patients required outpatient appointments.</p></div><div><h3>Discussion</h3><p>Over 40% of queries were resolved thanks to the electronic consultation system in an average of 2 days, otherwise patients would have been referred to specialized care.</p></div>","PeriodicalId":94193,"journal":{"name":"Reumatologia clinica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9796482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Neutrophils, neutrophil extracellular traps, and rheumatoid arthritis: An updated review for clinicians","authors":"Beatriz Frade-Sosa, Raimon Sanmartí","doi":"10.1016/j.reumae.2023.10.002","DOIUrl":"10.1016/j.reumae.2023.10.002","url":null,"abstract":"<div><p>Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by the presence of autoantibodies. Research on the pathogenic mechanisms involved in systemic autoimmune diseases has largely focused on the involvement of the adaptive immune system with dysregulated responses of T and B cells. However, in recent years, there is increasing evidence of the significant role played by the innate immune system, particularly neutrophils, in these diseases, particularly in RA. Neutrophil extracellular traps (NETs) are extracellular structures composed of remodeled and concentrated chromatin with DNA, histones, and neutrophil proteins, and were first described in 2004. It has been studied that NETs may play a pathogenic role in RA and could be a source of autoantigens, increasing the immune response in the form of autoantibodies in this disease. The possible role of NETs and other markers of neutrophil activation as biomarkers of activity in RA and other immune-mediated diseases has also been studied.</p><p>This article reviews the role of NETs in RA. It discusses the role of neutrophils and the latest advances in NETs, especially their involvement in autoimmune phenomena in RA. Finally, a literature review is conducted on the determination of NETs in peripheral blood and their relationship as a biomarker of RA activity, as well as their potential role in disease monitoring.</p></div>","PeriodicalId":94193,"journal":{"name":"Reumatologia clinica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49695595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cristina Membrive-Jiménez , Carlos Sánchez-Piedra , Olga Martínez-González , Javier García-González , Lorena Expósito-Pérez , Cristina Bohórquez-Heras , Cristina Campos-Fernández , Fernando Sanchez-Alonso , Rafael Cáliz-Cáliz , Isabel Castrejón-Fernández
{"title":"Safety and effectiveness of bDMARDs during pregnancy in patients with rheumatic diseases: Real-world data from the BIOBADASER registry","authors":"Cristina Membrive-Jiménez , Carlos Sánchez-Piedra , Olga Martínez-González , Javier García-González , Lorena Expósito-Pérez , Cristina Bohórquez-Heras , Cristina Campos-Fernández , Fernando Sanchez-Alonso , Rafael Cáliz-Cáliz , Isabel Castrejón-Fernández","doi":"10.1016/j.reumae.2023.02.005","DOIUrl":"https://doi.org/10.1016/j.reumae.2023.02.005","url":null,"abstract":"<div><h3>Introduction</h3><p>Inflammatory rheumatic diseases usually affect women of childbearing age treated with biologic drugs. However, there is a lack of literature on the efficacy and toxicity of biologic disease-modifying drugs during pregnancy. The aim of this study was to determine the presence of pregnant patients treated with bDMARDs in a real-world dataset and to examine the impact of pregnancy and lactation on the evolution of rheumatic disease in a registry of Spanish patients.</p></div><div><h3>Method</h3><p>This was a multicentre prospective study with a real-world setting. Information was obtained from BIOBADASER registry. Patients included are women who got pregnant until November 2020 from 19 rheumatology units. We conducted proportions, means, and standard deviations (SD) to describe the study population and the use of treatments. <em>T</em>-test and Chi-square test were applied to assess differences between groups.</p></div><div><h3>Result</h3><p>Ninety cases of pregnancy were registered (<em>n</em> <!-->=<!--> <!-->68 full-term pregnancies; <em>n</em> <!-->=<!--> <!-->22 spontaneous miscarriages). Most of the cases discontinued bDMARDs during pregnancy (78.9%) but 13 cases continued treatment during pregnancy, mainly using certolizumab pegol. These cases were obtaining better management of rheumatic disease, although the differences were not statistically significant [DAS28-CRP, 2.9 (SD: 1.6) vs. 2.0 (1.2), <em>p</em> <!-->=<!--> <!-->.255; DAS28-ESR, 2.2 (1.0) vs. 1.7 (.5), <em>p</em> <!-->=<!--> <!-->.266]. No serious adverse events were reported during pregnancy and lactation.</p></div><div><h3>Conclusion</h3><p>Being pregnant is still an uncommon condition in patients with rheumatic diseases and using bDMARDs. Our results show that rheumatic disease tended to progress better during pregnancy in patients who continued to take bDMARDs.</p></div>","PeriodicalId":94193,"journal":{"name":"Reumatologia clinica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71732680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}